Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079863957> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2079863957 endingPage "1204" @default.
- W2079863957 startingPage "1202" @default.
- W2079863957 abstract "Residual β-cell function in patients with type 1 diabetes has been generally determined by C-peptide response to stimulation by a liquid mixed-meal tolerance test (MMTT) or intravenous glucagon (1). Early trials assessed benefits of therapy by frequency and duration of the clinical remission phase in which minimal or no exogenous insulin was needed to maintain euglycemia (reviewed in 2). What is now needed is the most sensitive, and not necessarily the most physiologic measure, so that any improvement in β-cell function during a clinical trial can be detected. Both the MMTT and the intravenous glucagon test have practical limitations. The MMTT takes 2–4 h to complete, and the stimulus is subject to variations in gastrointestinal absorption, while the intravenous glucagon test often invokes nausea.In contrast, the use of intravenous arginine to stimulate and measure β-cell secretion takes only a few minutes to perform, circumvents gastrointestinal variation, and is clinically well tolerated. In addition, responses to this nonglucose secretagogue have been demonstrated to persist after the diagnosis of diabetes at a time when responses to glucose are gone (3–6). Our goal was to determine whether arginine-stimulated C-peptide could be used in lieu of MMTT as an outcome measure for intervention studies in recent-onset type 1 diabetes.Institutional review board approval and informed consent were obtained before the study began. Nineteen subjects between 7–42 and 1–24 …" @default.
- W2079863957 created "2016-06-24" @default.
- W2079863957 creator A5020555978 @default.
- W2079863957 creator A5037503691 @default.
- W2079863957 creator A5084868086 @default.
- W2079863957 date "2004-04-26" @default.
- W2079863957 modified "2023-09-25" @default.
- W2079863957 title "The Case for Intravenous Arginine Stimulation In Lieu of Mixed-Meal Tolerance Tests as Outcome Measure for Intervention Studies in Recent-Onset Type 1 Diabetes" @default.
- W2079863957 cites W1988261599 @default.
- W2079863957 cites W1996358492 @default.
- W2079863957 cites W2046072378 @default.
- W2079863957 cites W2046307613 @default.
- W2079863957 cites W2078591783 @default.
- W2079863957 cites W2079061697 @default.
- W2079863957 cites W2088073185 @default.
- W2079863957 cites W2090278466 @default.
- W2079863957 cites W2100030166 @default.
- W2079863957 cites W2102915416 @default.
- W2079863957 cites W2124111875 @default.
- W2079863957 cites W2129976178 @default.
- W2079863957 cites W2139988554 @default.
- W2079863957 cites W2159852644 @default.
- W2079863957 cites W2180032360 @default.
- W2079863957 cites W2326904657 @default.
- W2079863957 doi "https://doi.org/10.2337/diacare.27.5.1202" @default.
- W2079863957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15111546" @default.
- W2079863957 hasPublicationYear "2004" @default.
- W2079863957 type Work @default.
- W2079863957 sameAs 2079863957 @default.
- W2079863957 citedByCount "17" @default.
- W2079863957 countsByYear W20798639572012 @default.
- W2079863957 countsByYear W20798639572013 @default.
- W2079863957 countsByYear W20798639572015 @default.
- W2079863957 countsByYear W20798639572018 @default.
- W2079863957 countsByYear W20798639572020 @default.
- W2079863957 countsByYear W20798639572021 @default.
- W2079863957 crossrefType "journal-article" @default.
- W2079863957 hasAuthorship W2079863957A5020555978 @default.
- W2079863957 hasAuthorship W2079863957A5037503691 @default.
- W2079863957 hasAuthorship W2079863957A5084868086 @default.
- W2079863957 hasConcept C118552586 @default.
- W2079863957 hasConcept C126322002 @default.
- W2079863957 hasConcept C134018914 @default.
- W2079863957 hasConcept C2777180221 @default.
- W2079863957 hasConcept C2778345441 @default.
- W2079863957 hasConcept C2780665704 @default.
- W2079863957 hasConcept C555293320 @default.
- W2079863957 hasConcept C71924100 @default.
- W2079863957 hasConceptScore W2079863957C118552586 @default.
- W2079863957 hasConceptScore W2079863957C126322002 @default.
- W2079863957 hasConceptScore W2079863957C134018914 @default.
- W2079863957 hasConceptScore W2079863957C2777180221 @default.
- W2079863957 hasConceptScore W2079863957C2778345441 @default.
- W2079863957 hasConceptScore W2079863957C2780665704 @default.
- W2079863957 hasConceptScore W2079863957C555293320 @default.
- W2079863957 hasConceptScore W2079863957C71924100 @default.
- W2079863957 hasIssue "5" @default.
- W2079863957 hasLocation W20798639571 @default.
- W2079863957 hasLocation W20798639572 @default.
- W2079863957 hasOpenAccess W2079863957 @default.
- W2079863957 hasPrimaryLocation W20798639571 @default.
- W2079863957 hasRelatedWork W1563850031 @default.
- W2079863957 hasRelatedWork W1994487495 @default.
- W2079863957 hasRelatedWork W2045367862 @default.
- W2079863957 hasRelatedWork W2074686124 @default.
- W2079863957 hasRelatedWork W2287636357 @default.
- W2079863957 hasRelatedWork W2415759662 @default.
- W2079863957 hasRelatedWork W2800776805 @default.
- W2079863957 hasRelatedWork W3036934084 @default.
- W2079863957 hasRelatedWork W3081818426 @default.
- W2079863957 hasRelatedWork W3132313534 @default.
- W2079863957 hasVolume "27" @default.
- W2079863957 isParatext "false" @default.
- W2079863957 isRetracted "false" @default.
- W2079863957 magId "2079863957" @default.
- W2079863957 workType "article" @default.